European Astronaut Centre (EAC), Space Medicine Team, Cologne, Germany.
German Aerospace Center (DLR), Institute of Aerospace Medicine, Cologne, Germany.
Z Med Phys. 2024 Feb;34(1):111-139. doi: 10.1016/j.zemedi.2023.03.001. Epub 2023 May 22.
Ionizing radiation in general and mixed fields of space radiation in particular pose a risk of serious harm to human health. The risk of such adverse effects increases with the duration of the mission, and for all missions outside the protective properties of the Earth's magnetic field and atmosphere. Accordingly, radiation protection is of central importance for all human spaceflight, which is recognized by all international space agencies. To date various systems, analyze and determine the exposure to ionizing radiation within the environment and to the crew onboard the International Space Station (ISS). In addition to this operational monitoring, experiments and technology demonstrations are carried out. This to further enhance systems capabilities, to prepare for exploratory missions, to the Deep Space Gateway and/or to enable for human presence at other celestial bodies. Subsequently the European Space Agency (ESA) decided early to support the development of an active personal dosimeter. Under the auspices of the European Space Research and Technology Center (ESTEC) together with the European Astronaut Center's (EAC) Medical Operations and Space Medicine (HRE-OM) team, a European industrial consortium was formed to develop, build, and test this system. To complete the ESA Active Dosimeter (EAD) Technology Demonstration in space, EAD components were delivered to ISS with the ESA's space missions 'iriss' and 'proxima' in 2015 and 2016. This marked Phase 1 (2015) and 2 (2016-2017) of the EAD Technology Demonstration to which focus is given in this publication. All EAD systems and their functionalities, the different radiation detector, their properties, and calibrations procedures are described. Emphasis is first on the "iriss" mission of September 2015, that provided a complete set of data for an entire space mission from launch to landing, for the first time. Data obtained during Phase 2 in 2016-2017 are discussed thereafter. Measurements with the active radiation detectors of the EAD system provided data of the absorbed dose, dose equivalent, quality factor as well as the various dose contributions during the crossings of the South Atlantic Anomaly (SAA) and/or resulting from galactic cosmic radiation (GCR). Results of the in-flight cross-calibrations among the internal sensors of the EAD systems are discussed and alternative usage of the EAD Mobile Units as area monitors at various different locations inside the ISS is described.
电离辐射一般和空间辐射混合场尤其对人类健康构成严重危害的风险。这种不利影响的风险随着任务的持续时间而增加,并且对于所有在地球磁场和大气层保护之外的任务都是如此。因此,辐射防护对于所有载人航天飞行都至关重要,这一点得到了所有国际航天机构的认可。迄今为止,已经有各种系统用于分析和确定国际空间站(ISS)内环境和机组人员的电离辐射暴露情况。除了这种运行监测之外,还进行了实验和技术演示。这是为了进一步提高系统能力,为探索性任务做准备,为深空门户和/或使人类能够在其他天体上存在做准备。随后,欧洲航天局(ESA)决定尽早支持开发主动个人剂量计。在欧洲空间研究与技术中心(ESTEC)的主持下,与欧洲航天员中心的医疗操作和空间医学(HRE-OM)团队一起,组建了一个欧洲工业联盟,以开发、构建和测试该系统。为了在太空中完成 ESA 主动剂量计(EAD)技术演示,ESA 主动剂量计组件于 2015 年和 2016 年随 ESA 的“iriss”和“proxima”太空任务被运送到国际空间站。这标志着 EAD 技术演示的第一阶段(2015 年)和第二阶段(2016-2017 年),本出版物重点介绍了这两个阶段。本文描述了所有 EAD 系统及其功能、不同的辐射探测器、它们的特性和校准程序。首先重点介绍 2015 年 9 月的“iriss”任务,这是首次提供了从发射到着陆的整个太空任务的完整数据集。此后讨论了 2016-2017 年第二阶段获得的数据。EAD 系统的主动辐射探测器的测量结果提供了吸收剂量、剂量当量、品质因数以及在穿越南大西洋异常(SAA)和/或银河宇宙辐射(GCR)时的各种剂量贡献的数据。讨论了 EAD 系统内部传感器之间的飞行中交叉校准结果,并描述了 EAD 移动单元作为国际空间站内不同位置的区域监测器的替代用途。